Interventions to treat patients with diabetic nephropathy were generally considered of high clinical relevance, in particular the treatment of hypertension in patients with nephropathy (4.9), and, more specifically, use of ACE-inhibitors in diabetic nephropathy (4.5). This evidence concerns the gene ACE and Nephropathy.